vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Perella Weinberg Partners (PWP). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $219.2M, roughly 1.2× Perella Weinberg Partners). Perella Weinberg Partners runs the higher net margin — 6.3% vs 0.7%, a 5.6% gap on every dollar of revenue. On growth, Perella Weinberg Partners posted the faster year-over-year revenue change (-2.9% vs -16.5%). Perella Weinberg Partners produced more free cash flow last quarter ($30.5M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.

HCM vs PWP — Head-to-Head

Bigger by revenue
HCM
HCM
1.2× larger
HCM
$270.8M
$219.2M
PWP
Growing faster (revenue YoY)
PWP
PWP
+13.7% gap
PWP
-2.9%
-16.5%
HCM
Higher net margin
PWP
PWP
5.6% more per $
PWP
6.3%
0.7%
HCM
More free cash flow
PWP
PWP
$27.1M more FCF
PWP
$30.5M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
PWP
PWP
Revenue
$270.8M
$219.2M
Net Profit
$2.0M
$13.8M
Gross Margin
37.7%
Operating Margin
-13.2%
8.5%
Net Margin
0.7%
6.3%
Revenue YoY
-16.5%
-2.9%
Net Profit YoY
-83.6%
EPS (diluted)
$0.00
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PWP
PWP
Q4 25
$270.8M
$219.2M
Q3 25
$164.6M
Q2 25
$277.7M
$155.3M
Q1 25
$324.5M
$211.8M
Q4 24
$225.7M
Q3 24
$278.2M
Q2 24
$305.7M
$272.0M
Q1 24
$102.1M
Net Profit
HCM
HCM
PWP
PWP
Q4 25
$2.0M
$13.8M
Q3 25
$6.0M
Q2 25
$455.0M
$2.7M
Q1 25
$11.9M
$17.3M
Q4 24
Q3 24
$16.4M
Q2 24
$25.8M
$-66.0M
Q1 24
$-35.8M
Gross Margin
HCM
HCM
PWP
PWP
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
PWP
PWP
Q4 25
-13.2%
8.5%
Q3 25
5.4%
Q2 25
-1.3%
5.8%
Q1 25
-5.0%
5.5%
Q4 24
Q3 24
12.9%
Q2 24
-9.0%
-30.2%
Q1 24
-52.4%
Net Margin
HCM
HCM
PWP
PWP
Q4 25
0.7%
6.3%
Q3 25
3.6%
Q2 25
163.8%
1.8%
Q1 25
3.7%
8.2%
Q4 24
Q3 24
5.9%
Q2 24
8.4%
-24.3%
Q1 24
-35.1%
EPS (diluted)
HCM
HCM
PWP
PWP
Q4 25
$0.00
$0.11
Q3 25
$0.08
Q2 25
$0.52
$0.04
Q1 25
$0.01
$0.24
Q4 24
Q3 24
$0.24
Q2 24
$0.03
$-1.21
Q1 24
$-0.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PWP
PWP
Cash + ST InvestmentsLiquidity on hand
$1.4B
$255.9M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$-127.4M
Total Assets
$1.8B
$797.6M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PWP
PWP
Q4 25
$1.4B
$255.9M
Q3 25
$185.5M
Q2 25
$1.4B
$145.0M
Q1 25
$836.1M
$111.2M
Q4 24
$407.4M
Q3 24
$335.1M
Q2 24
$802.5M
$185.3M
Q1 24
$156.7M
Total Debt
HCM
HCM
PWP
PWP
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
PWP
PWP
Q4 25
$1.2B
$-127.4M
Q3 25
$-302.4M
Q2 25
$1.2B
$-318.4M
Q1 25
$759.9M
$-323.1M
Q4 24
$-421.4M
Q3 24
$-360.8M
Q2 24
$740.1M
$-283.0M
Q1 24
$161.9M
Total Assets
HCM
HCM
PWP
PWP
Q4 25
$1.8B
$797.6M
Q3 25
$650.2M
Q2 25
$1.8B
$606.7M
Q1 25
$1.3B
$570.5M
Q4 24
$876.8M
Q3 24
$810.9M
Q2 24
$1.3B
$645.5M
Q1 24
$583.6M
Debt / Equity
HCM
HCM
PWP
PWP
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PWP
PWP
Operating Cash FlowLast quarter
$8.2M
$34.8M
Free Cash FlowOCF − Capex
$3.4M
$30.5M
FCF MarginFCF / Revenue
1.2%
13.9%
Capex IntensityCapex / Revenue
1.8%
2.0%
Cash ConversionOCF / Net Profit
4.21×
2.52×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-34.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PWP
PWP
Q4 25
$8.2M
$34.8M
Q3 25
$59.2M
Q2 25
$-72.9M
$56.1M
Q1 25
$40.3M
$-176.5M
Q4 24
$223.4M
Q3 24
$200.3M
Q2 24
$-39.8M
$90.0M
Q1 24
$-206.3M
Free Cash Flow
HCM
HCM
PWP
PWP
Q4 25
$3.4M
$30.5M
Q3 25
$57.6M
Q2 25
$-82.2M
$55.3M
Q1 25
$32.5M
$-177.6M
Q4 24
$207.0M
Q3 24
$199.3M
Q2 24
$-49.9M
$83.7M
Q1 24
$-214.8M
FCF Margin
HCM
HCM
PWP
PWP
Q4 25
1.2%
13.9%
Q3 25
35.0%
Q2 25
-29.6%
35.6%
Q1 25
10.0%
-83.8%
Q4 24
91.7%
Q3 24
71.6%
Q2 24
-16.3%
30.8%
Q1 24
-210.3%
Capex Intensity
HCM
HCM
PWP
PWP
Q4 25
1.8%
2.0%
Q3 25
0.9%
Q2 25
3.3%
0.5%
Q1 25
2.4%
0.5%
Q4 24
7.3%
Q3 24
0.4%
Q2 24
3.3%
2.3%
Q1 24
8.3%
Cash Conversion
HCM
HCM
PWP
PWP
Q4 25
4.21×
2.52×
Q3 25
9.85×
Q2 25
-0.16×
20.50×
Q1 25
3.38×
-10.18×
Q4 24
Q3 24
12.23×
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons